Can-Fite BioPharma Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Can-Fite BioPharma Ltd. (CANF) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $8.00 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2026-03-26
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $8.00 20-F · filed 2026-03-26 | |
| 2024-12-31 | $60.00 20-F · filed 2026-03-26 | $0.02 20-F · filed 2025-04-14 |
| 2023-12-31 | $30.00 20-F · filed 2026-03-26 | $0.01 20-F · filed 2024-03-28 |
| 2022-12-31 | $0.02 20-F · filed 2025-04-14 | |
| 2021-12-31 | $0.18 20-F · filed 2024-03-28 | |
| 2020-12-31 | $0.16 20-F · filed 2022-03-24 |